Wang Xin, Li Yijiong, Zhang Ruihua, Pang Chao, Jiao Xiaoqing, Zhu Zhenlong, Wang Zhengmin
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Feb;33(2):225-30.
To investigate the expression of kisspeptin in gastric adenocarcinoma and its effect on the proliferation and migration of gastric cancer cells.
The level of kisspeptin in 50 gastric cancer tissues and their paracancerous tissues were detected by quantitative real-time PCR and Western blotting. Kisspeptin-siRNA,control-siRNA,p EGFP-N1-kisspeptin,p EGFP-N1 were separately transfected into MKN-45 gastric cancer cells. After 48-hour culture,the levels of matrix metalloproteinase-2( MMP-2),β-catenin,C-myc,MMP-9,kisspeptin were detected by Western blotting; MTT assay was used to detect the proliferation of MKN-45 cells; wound healing assay was performed to assess the migration ability of MKN-45 cells. After MKN-45 cells were treated with Wnt / β-catenin signal pathway inhibitor FH535,MTT assay and flow cytometry were used to evaluate cell proliferation ability and cell apoptosis,respectively.
Kisspeptin expression in gastric adenocarcinoma tissues was significantly lower than that of the adjacent normal tissues. The cell survival rate and migration rate of p EGFP-N1-kisspeptin group were significantly lower than those of p EGFP-N1 group. Cell survival rate and migration rate of kisspeptin-siRNA group were significantly higher than those of control siRNA group. The levels of MMP-9,MMP-2,β-catenin and C-myc in p EGFP-N1-kisspeptin group were significantly lower than those in p EGFP-N1 group. The levels of MMP-9, MMP-2, β-catenin and C-myc in kisspeptin-siRNA group were significantly higher than those in control-siRNA group. The proliferation and migration trend of gastric cancer cells treated with FH535 was similar to that of the p EGFP-N1-kisspeptin group.
The expression of kisspeptin decreases in gastric cancer tissues,and kisspeptin can interact with Wnt / β-catenin signaling pathway to inhibit the proliferation and migration of gastric cancer cells.
探讨胃泌素释放肽(kisspeptin)在胃腺癌中的表达及其对胃癌细胞增殖和迁移的影响。
采用定量实时荧光定量聚合酶链反应(qRT-PCR)和蛋白质免疫印迹法(Western blotting)检测50例胃癌组织及其癌旁组织中kisspeptin的水平。将kisspeptin-siRNA、对照-siRNA、pEGFP-N1-kisspeptin、pEGFP-N1分别转染至MKN-45胃癌细胞。培养48小时后,采用Western blotting检测基质金属蛋白酶-2(MMP-2)、β-连环蛋白(β-catenin)、C-myc、MMP-9、kisspeptin的水平;采用噻唑蓝比色法(MTT法)检测MKN-45细胞的增殖;采用划痕实验评估MKN-45细胞的迁移能力。用Wnt/β-连环蛋白信号通路抑制剂FH535处理MKN-45细胞后,分别采用MTT法和流式细胞术评估细胞增殖能力和细胞凋亡情况。
胃腺癌组织中kisspeptin的表达明显低于相邻正常组织。pEGFP-N1-kisspeptin组的细胞存活率和迁移率明显低于pEGFP-N1组。kisspeptin-siRNA组的细胞存活率和迁移率明显高于对照siRNA组。pEGFP-N1-kisspeptin组中MMP-9、MMP-2、β-catenin和C-myc的水平明显低于pEGFP-N1组。kisspeptin-siRNA组中MMP-9、MMP-2、β-catenin和C-myc的水平明显高于对照-siRNA组。FH535处理的胃癌细胞的增殖和迁移趋势与pEGFP-N1-kisspeptin组相似。
胃癌组织中kisspeptin表达降低,且kisspeptin可与Wnt/β-连环蛋白信号通路相互作用,抑制胃癌细胞的增殖和迁移。